Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and tra…
Medical - Devices
GB, Watford [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -64.96 | 17.54 | 50.05 | |
| Graham Fair Price | 42.97 | 3.78 | 2.64 | |
| PEG | -63.84 | 0.29 | -0.81 | |
| Price/Book | 10.89 | 2.32 | 2.09 | |
| Price/Cash Flow | -45.70 | 50.43 | 92.87 | |
| Prices/Earnings | -45.50 | 32.68 | 59.96 | |
| Price/Sales | -45.50 | 4.23 | 7.75 | |
| Price/FCF | -45.70 | 50.43 | 92.87 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -3.66 | 0.68 | 0.71 | |
| Operating Margin | 10.07 | 0.16 | 0.14 | |
| ROA | 103.48 | < 0.005 | < 0.005 | |
| ROE | < 0.005 | 0.02 | 103.48 | |
| ROIC | 0.02 | 0.06 | 202.97 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.02 | < 0.005 | 408.13 | |
| Dividends QOQ | -0.38 | < 0.005 | -99.02 | |
| EBIT QOQ | -0.37 | 1.24 | 232.10 | |
| EPS QOQ | -0.74 | 1.12 | 50.73 | |
| FCF QOQ | 3.11 | 1.04 | -66.62 | |
| Revenue QOQ | -0.50 | 1.03 | 106.45 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 525.09 | 236.99 | -54.87 | |
| Days Sales Outstanding (DSO) | 67.72 | 41.89 | -38.14 | |
| Inventory Turnover | 0.17 | 0.38 | 121.57 | |
| Debt/Capitalization | 0.37 | 0.36 | -1.88 | |
| Quick Ratio | 0.60 | 0.72 | 20.13 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Bad
Fundamentals
Per Share Metrics
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 5.96 | 5.98 | 0.23 | |
| Cash | 0.35 | 0.35 | 0.23 | |
| Capex | -0.15 | -0.30 | -101.84 | |
| Free Cash Flow | 0.13 | 0.27 | 104.70 | |
| Revenue | 1.61 | 3.28 | 103.94 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Weak